Cardiac Resynchronization Therapy (and Multisite Pacing) in Pediatrics and Congenital Heart Disease: Five Years Experience in a Single Institution
- 29 December 2008
- journal article
- clinical trial
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 20 (1), 58-65
- https://doi.org/10.1111/j.1540-8167.2008.01274.x
Abstract
Introduction: Clinical evidence supports the use of cardiac resynchronization therapy (CRT) in adults with heart failure, but experience in pediatrics and congenital heart disease (CHD) is limited in terms of patient numbers and follow‐up. We sought to determine the functional assessment and clinical outcomes in pediatric and CHD CRT patients followed uniformly at one institution. Methods: Retrospective review of 60 consecutive patients who underwent CRT between 2002 and 2007. Results: At implantation, median age was 15.0 years (5 months to 47 years). Overall, 46 patients had CHD (77%) and 14 had dilated cardiomyopathy. Prior to CRT, 92% were on heart failure treatment drugs and 55% had pacemakers. Median follow‐up time was 0.7 years (1 day–5.3 years). Median QRS width decreased from 149 to 120 ms (P < 0.001). Median ejection fraction (EF) increased from 36% to 42% (P < 0.001) and improvement was particularly evident in the group with CHD. Of note, 8 of 13 patients with single ventricle morphology had a “strong CRT response,” defined as either an improvement of 2–3 ordinal points in NYHA classification and/or increased ventricular function by ≥ 10 EF units. Overall, an improvement in functional status was observed in 39 of 45 patients (87%) with sufficient follow‐up data. Conclusions: Children and CHD patients treated with CRT have acute improvement in ventricular function, but implantation may require individualized planning and unconventional approaches. Future important goals include preimplant determination of CRT responders in pediatric and CHD patients, optimizing lead placement and programing, as well as long‐term CRT device management issues.Keywords
This publication has 25 references indexed in Scilit:
- Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: Results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trialsAmerican Heart Journal, 2006
- The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart FailureNew England Journal of Medicine, 2005
- Effect of chronic right ventricular apical pacing on left ventricular functionThe American Journal of Cardiology, 2005
- Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart FailureNew England Journal of Medicine, 2004
- Dilated Cardiomyopathy Associated with Dual-Chamber Pacing in Infants:. Improvement Through Either Left Ventricular Cardiac Resynchronization or Programming the Pacemaker Off Allowing Intrinsic Normal ConductionJournal of Cardiovascular Electrophysiology, 2004
- Combined Cardiac Resynchronization and Implantable Cardioversion Defibrillation in Advanced Chronic Heart FailureJAMA, 2003
- Cardiac Resynchronization and Death From Progressive Heart FailureJAMA, 2003
- ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary ArticleCirculation, 2002
- Cardiac Resynchronization in Chronic Heart FailureNew England Journal of Medicine, 2002
- Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction DelayNew England Journal of Medicine, 2001